↓ Skip to main content

Pomalidomide and Dexamethasone Are Effective in Relapsed or Refractory Multiple Myeloma in a Real-Life Setting: A Multicenter Retrospective Study in Taiwan

Overview of attention for article published in Frontiers in oncology, May 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
9 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pomalidomide and Dexamethasone Are Effective in Relapsed or Refractory Multiple Myeloma in a Real-Life Setting: A Multicenter Retrospective Study in Taiwan
Published in
Frontiers in oncology, May 2021
DOI 10.3389/fonc.2021.695410
Pubmed ID
Authors

Yu-Chin Hung, Jyh-Pyng Gau, Shang-Yi Huang, Bor-Sheng Ko, Chieh-Lin Jerry Teng

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 9 100%

Demographic breakdown

Readers by professional status Count As %
Professor 1 11%
Other 1 11%
Student > Postgraduate 1 11%
Student > Master 1 11%
Unknown 5 56%
Readers by discipline Count As %
Nursing and Health Professions 1 11%
Physics and Astronomy 1 11%
Design 1 11%
Unknown 6 67%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 March 2022.
All research outputs
#16,274,398
of 26,163,973 outputs
Outputs from Frontiers in oncology
#5,182
of 22,913 outputs
Outputs of similar age
#243,652
of 464,577 outputs
Outputs of similar age from Frontiers in oncology
#274
of 1,387 outputs
Altmetric has tracked 26,163,973 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,913 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 464,577 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,387 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.